These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18267291)

  • 1. Nursing and multidisciplinary interventions for Parkinson's disease: what is the evidence?
    Hagell P
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S501-8. PubMed ID: 18267291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a Regional Australian Nurse-Led Parkinson's Service Using the Context, Input, Process, and Product Evaluation Model.
    Jones B; Hopkins G; Wherry SA; Lueck CJ; Das CP; Dugdale P
    Clin Nurse Spec; 2016; 30(5):264-70. PubMed ID: 27509562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stakeholder perceptions of components of a Parkinson disease care management intervention, care coordination for health promotion and activities in Parkinson's disease (CHAPS).
    Connor KI; Siebens HC; Mittman BS; McNeese-Smith DK; Ganz DA; Barry F; Edwards LK; McGowan MG; Cheng EM; Vickrey BG
    BMC Neurol; 2020 Dec; 20(1):437. PubMed ID: 33267827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The integrative care of Parkinson's disease: a systematic review.
    Prizer LP; Browner N
    J Parkinsons Dis; 2012; 2(2):79-86. PubMed ID: 23939435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the direct and indirect costs associated with Parkinson's disease.
    Rodríguez-Blázquez C; Forjaz MJ; Lizán L; Paz S; Martínez-Martín P
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):889-911. PubMed ID: 26511768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis.
    Fundament T; Eldridge PR; Green AL; Whone AL; Taylor RS; Williams AC; Schuepbach WM
    PLoS One; 2016; 11(7):e0159340. PubMed ID: 27441637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary care for patients with Parkinson's disease.
    van der Marck MA; Kalf JG; Sturkenboom IH; Nijkrake MJ; Munneke M; Bloem BR
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S219-23. PubMed ID: 20082995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rehabilitational approach to the management of Parkinson's disease.
    Rubenis J
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S495-7. PubMed ID: 18267289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the health-related quality of life and economic impact of Parkinson's disease.
    Dowding CH; Shenton CL; Salek SS
    Drugs Aging; 2006; 23(9):693-721. PubMed ID: 17020395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost and quality aspects in the treatment of Parkinson's disease].
    Müller T; Dodel R; Fritze J
    Z Arztl Fortbild Qualitatssich; 2006; 100(4):291-5. PubMed ID: 16878798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the role of the Parkinson's disease nurse specialist.
    Reynolds H; Wilson-Barnett J; Richardson G
    Int J Nurs Stud; 2000 Aug; 37(4):337-49. PubMed ID: 10760541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of subthalmic nucleus deep brain stimulation for the treatment of advanced Parkinson disease in Hong Kong: a prospective study.
    Zhu XL; Chan DT; Lau CK; Poon WS; Mok VC; Chan AY; Wong LK; Yeung JH; Leung MC; Tang VY; Wong RK; Yeung C
    World Neurosurg; 2014 Dec; 82(6):987-93. PubMed ID: 25175275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions.
    Siderowf AD; Holloway RG; Stern MB
    Mov Disord; 2000 May; 15(3):439-45. PubMed ID: 10830407
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluating rehabilitation using cost-consequences analysis: an example in Parkinson's disease.
    Gage H; Kaye J; Owen C; Trend P; Wade D
    Clin Rehabil; 2006 Mar; 20(3):232-8. PubMed ID: 16634342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic and health-related quality of life considerations of new therapies in Parkinson's disease.
    Rubenstein LM; DeLeo A; Chrischilles EA
    Pharmacoeconomics; 2001; 19(7):729-52. PubMed ID: 11548910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness Analysis of Deep Brain Stimulation in Patients with Parkinson's Disease in Japan.
    Kawamoto Y; Mouri M; Taira T; Iseki H; Masamune K
    World Neurosurg; 2016 May; 89():628-635.e1. PubMed ID: 26704203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nursing interventions for a chronically ill, nonadherent teenager with a psychiatric diagnosis.
    Sieben D; Steinmiller EA; Bertolino J
    J Spec Pediatr Nurs; 2003; 8(4):121-9. PubMed ID: 14677318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility, appropriateness, meaningfulness and effectiveness of nursing interventions on the well-being of people with Parkinson's disease and their caregivers living in the community: a mixed-methods systematic review protocol.
    Wosinski J; Delmas P; Bouwers B; Stormacq C; Kiszio B
    JBI Database System Rev Implement Rep; 2015 May; 13(4):14-29. PubMed ID: 26447070
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluating community-based Parkinson's disease nurse specialists: rationale, methodology, and representativeness of patient sample in a large randomized controlled trial.
    Hurwitz B; Bajekal M; Jarman B
    Adv Neurol; 1999; 80():431-8. PubMed ID: 10410752
    [No Abstract]   [Full Text] [Related]  

  • 20. Traversing the network: a user-led Care Pathway approach to the management of Parkinson's disease in the community.
    Holloway M
    Health Soc Care Community; 2006 Jan; 14(1):63-73. PubMed ID: 16324188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.